FDA-cleared profile

AV Cardiac CT

Philips Medical Systems Nederland B.V. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.

Clinical role
Cardiac-CT visualization, coronary anatomy/function analysis, reporting and intervention-preparation support.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The device does not provide automatic diagnosis, clinical decisions or treatment recommendations. All outputs are reviewable and editable. Pre-PCI planning tools provide approximate vessel dimensions and C-arm angulation and are not for device selection or treatment decisions.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Gated conventional or spectral cardiac CT data, including coronary CT angiography datasets.
  • Who uses it?Intended users: Qualified medical professionals, including radiologists, cardiologists and 3D technologists.
  • What does the software produce?Output: Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.
  • What is its most important limitation?Key limitation: The device does not provide automatic diagnosis, clinical decisions or treatment recommendations. All outputs are reviewable and editable. Pre-PCI planning tools provide approximate vessel dimensions and C-arm angulation and are not for device selection or treatment decisions.

Clinical takeaway. Clinical role: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.

Evidence takeaway. Evidence from the reviewed source record: The K260169 technical study used 80 CCTA cases and three observers' manual reference annotations. It measures algorithm agreement and labeling performance rather than clinical diagnostic or treatment outcomes.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Cardiac-CT visualization, coronary anatomy/function analysis, reporting and intervention-preparation support.
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Gated conventional or spectral cardiac CT data, including coronary CT angiography datasets.
  • Exact FDA submission
  • Checked 2026-09-06
Output and clinician action
Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.
  • Exact FDA submission
  • Checked 2026-09-06
Care setting
Patients suspected of or diagnosed with coronary artery disease undergoing gated conventional or spectral cardiac CT.
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Qualified medical professionals, including radiologists, cardiologists and 3D technologists.
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
The device does not provide automatic diagnosis, clinical decisions or treatment recommendations. All outputs are reviewable and editable. Pre-PCI planning tools provide approximate vessel dimensions and C-arm angulation and are not for device selection or treatment decisions.
  • Exact FDA submission
  • Checked 2026-09-06
Evidence summary
The K260169 technical study used 80 CCTA cases and three observers' manual reference annotations. It measures algorithm agreement and labeling performance rather than clinical diagnostic or treatment outcomes.
  • Exact FDA submission
  • Checked 2026-09-06

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The K260169 technical study used 80 CCTA cases and three observers' manual reference annotations. It measures algorithm agreement and labeling performance rather than clinical diagnostic or treatment outcomes.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Reported sensitivity
91
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Major-vessel-label sensitivity in the technical CCTA performance evaluation, not diagnostic sensitivity for coronary artery disease.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

No disease-detection specificity was established by the reviewed technical-performance summary.

Coronary centerline overlap

0.93 overlap coefficient

  • EndpointCenterline overlap against manual reference
  • Population80 CCTA cases with three-observer manual reference annotations
  • Tested versionAV Cardiac CT configuration cleared in K260169

Major vessel-label sensitivity

91 percent

  • EndpointSensitivity for major coronary-vessel labeling
  • Population80 CCTA technical-performance cases
  • Tested versionAV Cardiac CT configuration cleared in K260169

K260169 CCTA coronary-analysis technical performance evaluation

  • DesignManufacturer technical-performance evaluation compared with three-observer manual reference annotations
  • Population80 CCTA cases from datasets spanning US, Europe and Asia
  • Scopeexact submission
  • Tested versionAV Cardiac CT configuration cleared in K260169
  • Samplen=80
  • IndependenceSponsor or vendor study

K260169

Endpoints include coronary centerline, label and lumen-segmentation agreement. The study is not an autonomous diagnosis or clinical-outcome study.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Gated conventional or spectral cardiac CT data, including coronary CT angiography datasets.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT

  2. Routing

    Source context, not route validation: The current AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT as an integrated component and describes DICOM image exchange features.

    Scope: Product family. Later AVW V15.1.3 documentation; it does not establish the exact K260169 installed release or interfaces.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-06 · DICOM Conformance Statement: Advanced Visualization Workspace V15.1.3

  3. AI processing

    Source context, not route validation: Standalone software-only medical device.

    Scope: Exact FDA submission. The summary does not establish a complete current hosting or network architecture.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT

  4. Returned objects

    Source context, not route validation: Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT

  5. Viewer/worklist/report

    Unresolved route: Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Standalone software-only medical device.
  • Exact FDA submission
  • Checked 2026-09-06

The summary does not establish a complete current hosting or network architecture.

Integration
The current AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT as an integrated component and describes DICOM image exchange features.
  • Product family
  • Checked 2026-09-06

Later AVW V15.1.3 documentation; it does not establish the exact K260169 installed release or interfaces.

Security
Philips' Responsible Disclosure Statement states that Philips maintains a global network of product security officers for developing and deploying security and privacy features for its products and services and for managing security events; that vulnerability reports to productsecurity@philips.com (PGP-encrypted) are acknowledged within two business days with a tracking number and an assigned contact; status updates approximately every 2-3 weeks; a 90-day resolution aim; and patch or advisory notification through existing customer notification processes. Vendor statement; no certification or test report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: the statement is on philips.com (Royal Philips) and covers Philips products and services; the FDA applicant entity appears in Philips' own BCR members list on documents.philips.com (Philips Ultrasound LLC, Philips Medical Systems Nederland B.V., Philips Healthcare (Suzhou), Philips Medical Systems DMC GmbH, Philips Medical Systems Technologies Ltd., Philips Oy). Corporate policy; exact-release scope is not established.

Monitoring
Philips' coordinated vulnerability disclosure policy states a global product security officer network, PGP-based reporting, acknowledgement within 2 business days, report tracking, updates every 2-3 weeks, a 90-day resolution aim and customer notification.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The policy names Philips generally and does not scope these commitments to any specific product release; exact-release scope is not established.

Current AVW DICOM family context

Philips' AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT within the AV Cardio Vascular Suite and describes receiving, storing, querying and exchanging DICOM images.

product family · checked 2026-09-06

This is current product-family documentation, not exact evidence for the K260169 configuration.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K260169
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-03-05
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
22Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored PubMed and ClinicalTrials candidate metadata snapshots were screened; both arrays were empty. No candidate evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, vendor documentation, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-06 - Exact FDA submission

    No public exact-version price or procurement record reviewed.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Philips Advanced Visualization cardiac CT reimbursement"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. A Philips reimbursement guide that surfaced was read; it covers interventional procedures and does not name this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-06 - Exact FDA submission

    Qualified-user intent does not establish a verified current training program.

8 sources - 3 history items

Source ledger

  1. FDA 510(k) K260169: AV Cardiac CT

    U.S. Food and Drug Administration - Accessed 2026-09-06

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, reportedSensitivity

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. AV Cardiac CT model card (K260169)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. DICOM Conformance Statement: Advanced Visualization Workspace V15.1.3

    Philips - Accessed 2026-09-06

    Scope: productFamily, implementationCapabilities

  8. Philips: Responsible Disclosure Statement

    Philips - Accessed 2026-10-26

    Scope: security

Research history

  1. K260169 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K253786

syngo.CT Coronary Cockpit

Siemens Medical Solutions USA, Inc.

Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2026-06-25
FDA-cleared K252217

CT VScore+

Canon Medical Informatics, Inc.

Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-11-28
FDA-cleared K251027

cvi42 Coronary Plaque Software Application

Circle Cardiovascular Imaging, Inc.

Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-10-27

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history